Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

456 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Preoperative Chemoradiation for Pancreatic Adenocarcinoma Does Not Increase 90-Day Postoperative Morbidity or Mortality.
Denbo JW, Bruno ML, Cloyd JM, Prakash L, Lee JE, Kim M, Crane CH, Koay EJ, Krishnan S, Das P, Minsky BD, Varadhachary G, Shroff R, Wolff R, Javle M, Overman MJ, Fogelman D, Aloia TA, Vauthey JN, Fleming JB, Katz MH. Denbo JW, et al. Among authors: shroff r. J Gastrointest Surg. 2016 Dec;20(12):1975-1985. doi: 10.1007/s11605-016-3286-9. Epub 2016 Oct 11. J Gastrointest Surg. 2016. PMID: 27730398
Molecular characterization of gallbladder cancer using somatic mutation profiling.
Javle M, Rashid A, Churi C, Kar S, Zuo M, Eterovic AK, Nogueras-Gonzalez GM, Janku F, Shroff RT, Aloia TA, Vauthey JN, Curley S, Mills G, Roa I. Javle M, et al. Hum Pathol. 2014 Apr;45(4):701-8. doi: 10.1016/j.humpath.2013.11.001. Epub 2013 Nov 12. Hum Pathol. 2014. PMID: 24508317 Free PMC article.
Does IGFR1 inhibition result in increased muscle mass loss in patients undergoing treatment for pancreatic cancer?
Fogelman DR, Holmes H, Mohammed K, Katz MH, Prado CM, Lieffers J, Garg N, Varadhachary GR, Shroff R, Overman MJ, Garrett C, Wolff RA, Javle M. Fogelman DR, et al. Among authors: shroff r. J Cachexia Sarcopenia Muscle. 2014 Dec;5(4):307-13. doi: 10.1007/s13539-014-0145-y. Epub 2014 Apr 17. J Cachexia Sarcopenia Muscle. 2014. PMID: 24740741 Free PMC article.
Second-line systemic treatment for advanced cholangiocarcinoma.
Rogers JE, Law L, Nguyen VD, Qiao W, Javle MM, Kaseb A, Shroff RT. Rogers JE, et al. J Gastrointest Oncol. 2014 Dec;5(6):408-13. doi: 10.3978/j.issn.2078-6891.2014.072. J Gastrointest Oncol. 2014. PMID: 25436118 Free PMC article.
Mutation profiling in cholangiocarcinoma: prognostic and therapeutic implications.
Churi CR, Shroff R, Wang Y, Rashid A, Kang HC, Weatherly J, Zuo M, Zinner R, Hong D, Meric-Bernstam F, Janku F, Crane CH, Mishra L, Vauthey JN, Wolff RA, Mills G, Javle M. Churi CR, et al. Among authors: shroff r. PLoS One. 2014 Dec 23;9(12):e115383. doi: 10.1371/journal.pone.0115383. eCollection 2014. PLoS One. 2014. PMID: 25536104 Free PMC article.
HER2/neu-directed therapy for biliary tract cancer.
Javle M, Churi C, Kang HC, Shroff R, Janku F, Surapaneni R, Zuo M, Barrera C, Alshamsi H, Krishnan S, Mishra L, Wolff RA, Kaseb AO, Thomas MB, Siegel AB. Javle M, et al. Among authors: shroff r. J Hematol Oncol. 2015 May 29;8:58. doi: 10.1186/s13045-015-0155-z. J Hematol Oncol. 2015. PMID: 26022204 Free PMC article.
456 results